GLP-1 receptor agonists are compounds studied for their interactions with glucagon-like peptide-1 receptors and downstream metabolic signaling pathways. Newer-generation compounds in this category also demonstrate activity at additional receptor targets including glucagon and amylin receptors, while some operate through entirely distinct mechanistic pathways independent of GLP-1 receptor activation.